The HLA-B27 allele is over-represented among human immunodeficiency virus type 1-infected long-term non-progressors. In these patients, strong CTL responses targeting HLA-B27-restricted viral epitopes have been associated with long-term asymptomatic survival. Indeed, loss of control of viraemia in HLA-B27 patients has been associated with CTL escape at position 264 in the immunodominant KK10 epitope. This CTL escape mutation in the viral Gag protein has been associated with severe viral attenuation and may require the presence of compensatory mutations before emerging. Here, we studied sequence evolution within HLA-B27-restricted CTL epitopes in the viral Gag protein during the course of infection of seven HLA-B27-positive patients. Longitudinal gag sequences obtained at different time points around the time of AIDS diagnosis were obtained and analysed for the presence of mutations in epitopes restricted by HLA-B27, and for potential compensatory mutations. Sequence variations were observed in the HLA-B27-restricted CTL epitopes IK9 and DR11, and the immunodominant KK10 epitope. However, the presence of sequence variations in the HLA-B27-restricted CTL epitopes could not be associated with an increase in viraemia in the majority of the patients studied. Furthermore, we observed low genetic diversity in the gag region of the viral variants throughout the course of infection, which is indicative of low viral replication and corresponds to the low viral load observed in the HLA-B27-positive patients. These data indicated that control of viral replication can be maintained in HLA-B27-positive patients despite the emergence of viral mutations in HLA-B27-restricted epitopes.
INTRODUCTION
Expression of certain HLA class I alleles is known to be associated with lower viral load and prolonged survival after human immunodeficiency virus type 1 (HIV-1) infection, of which HLA-B57 and HLA-B27 are the most studied (Carrington & O'Brien, 2003; Deeks & Walker, 2007; Gao et al., 2005; Kaslow et al., 1996; The International HIV Controllers Study, 2010) . CTLs play an important role in the protective effect of these HLA alleles, and the presence of HIV-specific CTLs restricted by HLA-B57 and HLA-B27 in early infection better defines disease progression than HLA genotype alone (Gao et al., 2005) . However, HIV-1 is able to escape from CTL responses through selection of mutations that abrogate CTL-mediated killing . Individuals carrying HLA-B57 show CTL escape from the immunodominant TW10 epitope through the T242N CTL escape mutation early after infection. The T242N mutation is known to have a negative effect on the replication capacity of the virus, leading to lower viral load Martinez-Picado et al., 2006) . Patients carrying the HLA-B27 allele also have low viral loads for long periods of time, indicative of efficient control of viral replication (Ammaranond et al., 2011; Goulder et al., 1997) . The importance of CTLs in the control of viral replication is underscored by the observation that viral escape from HLA-B27-restricted CTL epitope KK10 has been associated with loss of control of viraemia and disease progression (Ammaranond et al., 2011; Appay et al., 2002; Feeney et al., 2004; Goulder et al., 1997; Kelleher et al., 2001; Schneidewind et al., 2007) . The CTL escape mutation in this epitope is located at the R264 position and is most usually mediated by a mutation toward a lysine (K); however, mutations toward glycine (G), threonine (T) or glutamine (Q) have also been described (Ammaranond et al., 2005; Kelleher et al., 2001; Nietfield et al., 1995; O'Connell et al., 2010b; Schneidewind et al., 2008) . It has been hypothesized that the R264 escape mutation alone does not result in a viable virus and that compensatory mutations are essential before the escape variant can emerge (Kelleher et al., 2001 ).
Here, we studied the dynamics of mutations in HLA-B27-restricted CTL epitopes in gag from seven HLA-B27-positive patients during disease progression. Longitudinal gag sequences obtained at different time points during the course of infection and around AIDS diagnosis were analysed for the presence of mutations in HLA-B27-restricted CTL epitopes and potential compensatory mutations. Additionally, we analysed the impact of these mutations on viral load and disease progression.
RESULTS

Characteristics of HLA-B27-positive patients
Seven HLA-B27-positive patients, who were followed longitudinally in the Amsterdam Cohort Studies (ACS), were analysed in the present study. Patient characteristics are summarized in Table 1 . Two patients were already HIV-1-positive upon entry into the cohort and five patients seroconverted during follow-up. All patients progressed to AIDS without the use of antiretroviral therapy, an increasing viral load and declining number of CD4 + T-cells were observed over the course of infection (Fig. 1) . For all patients, serum samples from time points close to disease progression (between 5 years prior and 6 months after AIDS diagnosis) were available for analysis.
Sequence variation in CTL epitopes restricted by HLA-B27
The Gag region of HIV-1 present in serum from the patients was analysed. Per time point, between one and 13 gag sequences were generated to study sequence evolution within HLA-B27-restricted CTL epitopes over time.
In the viral sequences obtained from patient ACH19974, we observed three mutations (E42G, R43Q and V46L) in the EL9 epitope, which were only present in a single viral sequence obtained at a single time point. Of these mutations, only R43Q was located at an anchor residue and may have disrupted presentation of the epitope by HLA-B27. Furthermore, a single viral sequence containing a mutation in the DA9 epitope (F300L) was observed at 72 months after seroconversion. However, the viral sequences containing these mutations were not positively selected during the course of infection, indicating that there was no selective advantage for the viral variants. In epitope DR11, the R286K mutation was present in all viral sequences obtained at all time points studied. In patient ACH19974, the increase in the viral load observed at 77 months after seroconversion was not associated with emergence of mutations in HLA-B27-restricted epitopes in gag (Fig. 1a) .
In patient ACH19778, all of the observed viral sequences contained the V46L mutation in the EL9 epitope; however, this mutation was not associated with escape from presentation by HLA-B27. Additionally, the L50P mutation, which may represent an escape mutation located at the P9 anchor residue of the HLA-B27 EL9 epitope, was observed in a single viral sequence obtained at 65 months after seroconversion. However, viral variants containing this mutation apparently had no selective advantage throughout the course of infection. In the immunodominant epitope KK10, the L268M mutation was observed in all viral sequences from 65 and 85 months after seroconversion. The emergence of the L268M mutation was observed along with a 10-fold increase of viral load at 65 months after seroconversion, prior to the emergence of the most common R264K mutation (Fig. 1b) .
In patient ACH19490, no viral sequences were detectable in plasma obtained at the first two time points analysed (72 and 86 months after seroconversion). The K26S/A mutation in the IK9 epitope was observed in viral sequences obtained at 105 and 112 months after seroconversion. The R264G mutation in the KK10 epitope was first observed in a minority of viral sequences at 97 months after seroconversion and was present in all viral sequences obtained at later time points (Table 2) . Additionally, the I267V mutation in the KK10 epitope was observed in two out of four viral sequences obtained at 97 months after seroconversion; however, this mutation was not positively selected during the course of infection. The R286K mutation in the DR11 epitope was present in the majority of viral sequences obtained at 106 and 112 months after seroconversion in patient ACH19490. HIV-1 evolution in HLA-B27-positive patients
The emergence of mutations in the HLA-B27-restricted epitopes was not associated with a clear increase in viral load in this patient (Fig. 1c) .
In patient ACH19689, no viral sequences could be obtained from the first time point included in this study (70 months after seroconversion). In the IK9 epitope, the R20F mutation was observed in a single viral sequence obtained at 95 months after seroconversion; however, this mutation was not associated with a selective advantage for the virus and was not observed at later time points (Table 2 ). In the KK10 epitope, the R264G mutation was first observed in a minority of viral sequences at 95 months after seroconversion and was positively selected in all viral sequences obtained at later time points. Additionally, we observed the L268I and the L268M mutations in the KK10 epitope. The L268I mutation was present in the majority of viral sequences isolated from 84 months after seroconversion, but was not positively selected in the course of the disease. The L268M mutation was only observed at 95 months after seroconversion in three out of six viral sequences. This mutation has previously been associated with early escape from TCR recognition (Lichterfeld et al., 2007) and has been described to have a negative impact on replication kinetics of the R264G variant, but not the R264K variant (Schneidewind et al., 2008) . Here, mutations L268M and R264G were never seen in combination in a single viral sequence. Furthermore, we observed N271T/H mutation in the KK10 epitope at 95 months after seroconversion; these mutations were only observed in a minority of the viral sequences and were not positively selected. In the DR11 epitope, the mutation R284K was present in three out of four viral sequences observed at 84 months after seroconversion and was only present in the minority of viral sequences obtained at 95 months after seroconversion. Moreover, the emergence of mutations in CTL-restricted epitopes did not result in a strong increase in viral load during follow-up in patient ACH19689 (Fig. 1d) .
In patient ACH18897, the K26R mutation was observed in the majority of viral sequences isolated at 124 months after seroconversion and in one out of two sequences at 126 months after seroconversion in the IK9 epitope. In the immunodominant epitope KK10, the I266V mutation in the KK10 was only observed in one out of four viral variants at 124 months after seroconversion. The I267V mutation in the KK10 epitope was observed in one out of three viral variants sequenced at 81 months after seroconversion and was positively selected throughout the course of infection (Table 2) . Moreover, the L268M mutation was observed at 81 months after seroconversion. This mutation was lost at the next time point studied (124 months after seroconversion), but was observed again (one out of two viral sequences) at 126 months after seroconversion. Furthermore, the N271T mutation in the KK10 epitope was observed at 124 and 126 months after HIV-1 evolution in HLA-B27-positive patients seroconversion. The emergence of mutations in patient ACH18897 in the immunodominant KK10 epitope was first detectable in the minority of the viral population at 81 months after seroconversion and observed in all viral variants obtained later in infection after a 100-fold increase in viral load had occurred (Fig. 1e) . Furthermore, all viral sequences obtained from patient ACH18897 carried the R286K mutation in the DR11 epitope.
In patient ACH19322, no viral sequences could be obtained at 80 months after seroconversion. At the following time points studied, sequence variations were only observed in the KK10 epitope. The L268M mutation in the KK10 epitope was obtained in the majority of the detectable viral sequences at all time points analysed (Table 2 ).
Finally, in patient ACH19992, no viral sequence variation was observed in the IK9, EL9 and DR11 epitopes, whereas a single mutation (R305G) was found in the DA9 epitope in one out of 11 viral sequences obtained at 113 months after seroconversion. The mutation L268M in the KK10 epitope was observed in the majority of viral sequences at all time points. At 130 months after seroconversion, viral sequences with the N271H mutation in the KK10 epitope emerged in three out of 11 sequences, but this mutation was not observed at the later time point (Table 2) .
Compensatory mutations associated with the R264K/G mutation
The KK10 epitope has been described to be the immunodominant CTL epitope in most HLA-B27-positive patients (Goulder et al., 1997) . In this study, we showed that six out of seven patients had sequence variations in the KK10 epitope, yet only three patients had a mutation at the previously described position R264 (Nietfield et al., 1995) . The mutation at position R264 has been demonstrated to come at a fitness cost for the virus, which can be compensated by mutation S173A for R264K or E260D for R264G (Kelleher et al., 2001; Schneidewind et al., 2007) . Indeed, the S173A (patient ACH19778) and E260D (patients ACH19490 and ACH19689) mutations emerged in viral sequences obtained from time points close to disease progression. In patient ACH19778, the R264K mutation was always seen in the presence of the known S173A compensatory mutation, whereas the R264G mutation in patients ACH19490 and ACH19689 was observed alone and in combination with the E260D compensatory mutation. This suggested that the fitness cost associated with the R264G mutation was less severe as compared with the R264K mutation, confirming previous observations (Schneidewind et al., 2007) .
Viral evolution in gag sequences of HLA-B27 patients
Next, we analysed viral evolution in the gag sequences. We compared the number of amino acid changes in Gag relative to the HIV-1 subtype B consensus sequence in the viral sequences obtained from all patients over time (Fig. 2 , Table 3 ). We observed that the viral sequences studied had 2-24 aa differences as compared with the subtype B Gag consensus, which were located mostly outside of the HLA-B27-restricted CTL epitopes (Table 3 ). The number of amino acid differences relative to the subtype B consensus in Gag did not change significantly throughout disease progression in six out of seven HLA-B27-positive patients included in this study (Fig. 2) . However, in patient ACH19778, the number of changes in Gag steadily increased over the time points analysed (Fig. 2) . At 85 months after seroconversion, a significant increase (P50.0032) in the total number of amino acid changes in Gag was observed (Fig. 2) . This increase in amino acid changes coincided with the emergence of the R264K mutations in the HLA-B27-restricted epitope KK10.
Moreover, we analysed the genetic divergence of viral sequences isolated between consecutive time points (Table 3) . In all patients, genetic distances between viral isolates obtained from two closest time points were low, ranging from 0.009 to 0.029 %. Additionally, we calculated the ratio of non-synonymous and synonymous mutations (dN/dS ratio) to determine whether evolution was random due to error-prone reverse transcriptase and high viral turnover. A dN/dS ratio v1 indicates negative selection pressure to retain protein structure. A neutral dN/dS ratio *1 indicates an equal amount of non-synonymous and synonymous mutations showing no specific selective pressure on the protein. When the dN/dS ratio is w1 there is a positive selection, indicating pressure on the protein to change amino acid composition to gain fitness or evade immune response. When comparing gag sequences in HLA-B27-positive patients, all viral sequences showed negative selection pressure (0.09vdN/dSv0.34) to retain their protein structure (Table 3) .
DISCUSSION
HLA-B27 is enriched amongst HIV controllers compared with non-controllers in the Caucasian population (Bailey et al., 2006a; Lambotte et al., 2005) , and this association is believed to be a consequence of strong CTL responses (Carrington & O'Brien, 2003; Deeks & Walker, 2007; Gao et al., 2005) . However, in patients carrying this HLA allele, CTL escape in the immunodominant KK10 epitope can occur late in the infection, and has been associated with loss of control of viraemia and disease progression (Ammaranond et al., 2011; Appay et al., 2002; Feeney et al., 2004; Goulder et al., 1997; Kelleher et al., 2001; Schneidewind et al., 2007) . Here, we studied sequence evolution in HLA-B27-restricted CTL epitopes in the viral Gag protein during disease progression in seven HLA-B27-positive patients.
In agreement with previous reports (Ammaranond et al., 2005 (Ammaranond et al., , 2011 Appay et al., 2002; Feeney et al., 2004; Goulder et al., 1997; Kelleher et al., 2001; Nietfield et al., 1995; O'Connell et al., 2010b; Schneidewind et al., 2007 Schneidewind et al., , 2008 , mutation in the HLA-B27-restricted CTL epitopes was predominant in the immunodominant HLA-B27-restricted KK10 epitope in six out of seven patients. Nevertheless, sequence variations were also observed in the other HLA-B27-specific CTL epitopes.
Escape from the immunodominant KK10 CTL response restricted by HLA-B27 via the R264 position can be accomplished by mutation toward lysine (K), glycine (G), threonine (T) or glutamine (Q) (Ammaranond et al., 2005; Kelleher et al., 2001; Nietfield et al., 1995; O'Connell et al., 2010b; Schneidewind et al., 2008) . All these mutations decrease the binding affinity of the KK10 epitope to the HLA-B27 molecule, thereby limiting epitope presentation and preventing subsequent CTL-mediated lysis. In the present study, we only observed a mutation at this amino acid position in three patients: two patients developed the R264G mutation, whereas only one patient harboured the R264K mutation. This finding is in agreement with previous observations, where it was demonstrated that the R264K/G mutations appear in 10-50 % of the included HLA-B27-positive patients (Ammaranond et al., 2005; Cornelissen et al., 2009; Goulder et al., 1997; Kelleher et al., 2001; Schneidewind et al., 2007) .
The emergence of an escape mutation at position R264 in the KK10 epitope has been associated with an increase of viral load, indicating a loss of viraemic control (Ammaranond et al., 2011; Appay et al., 2002; Feeney et al., 2004; Goulder et al., 1997; Kelleher et al., 2001; Schneidewind et al., 2007) . In patient ACH19778, an increase in the viral load was observed *65 months after seroconversion, whereas the R264K mutation emerged 85 months after seroconversion. This indicates that the emergence of the R264K mutation is not associated with the increase in viral load in this patient. The emergence of the L268M mutation at 65 months after seroconversion could contribute to the observed increase in viral load at that time point. Moreover, CXCR4-using viral variants were first detected at 47 months after seroconversion in this patient and the presence of these CXCR4-using viral variants with high replicating capacity may additionally contribute to the increase in viral load ( Van't Wout et al., 1998) . In agreement with this, we also observed an increase in amino acid changes outside of the HLA-B27-restricted epitopes. In patient ACH18897, sequence variations in the KK10 epitope were observed in a minority of the viral sequences obtained 81 months after seroconversion (30 %) prior to 100-fold increase in viral load, and sequence variation in the KK10 epitope was observed in all viral sequences during disease progression of this patient. These data indicate that emergence of mutations in the KK10 epitope might have contributed to disease progression in two out of seven HLA-B27-positive patients included in this study.
Furthermore, in patients ACH19490 and ACH19689, the R264G mutations were observed in viral sequences obtained from all time points studied. Although the frequency of viruses carrying the mutation continuously increases over time, the viral load at the time points studied remained stable. Our findings confirm previous observations demonstrating that the emergence of a mutation at R264 in KK10 does not always result in an increase in plasma viral load (Ammaranond et al., 2011; Kelleher et al., 2001) .
In vitro studies have shown that the R264K escape mutation severely reduced viral replication capacity in comparison with the R264G mutation and that introduction of compensatory mutations can rescue this fitness cost (Kelleher et al., 2001; Schneidewind et al., 2007) . Interestingly, mutations that are able to compensate for the fitness cost associated with either R264K or R264G are located at different positions, with S173A and E260D serving as compensatory mutations for R264K and R264G, respectively. Here, we observed that the R264K mutation was only seen in combination with the S173A compensatory mutation. However, the emergence of the R264G mutation was not always accompanied by the E260D compensatory mutation at the initial emergence of this viral variant in these patients. This could suggest that the fitness cost associated with the R264G mutation is less severe as compared with the R264K mutation, confirming previous observations (Schneidewind et al., 2007) . Additionally, we observed other mutations in the KK10 epitope in the viral sequences. However, the presence of these mutations was not associated with an increase in viral load nor disease progression.
Although the KK10 CTL epitope is usually immunodominant in patients carrying HLA-B27, here we observed mutation R286K in the DR11 epitope in the viral sequences studied from four out of seven patients. The DR11 epitope with the R286K mutation is poorly presented by HLA-B27 according to the Stabilized Matrix Method (Tenzer et al., 2005) . In two patients, the R286K mutation was only observed at several time points during the course of infection, but did not have a selective advantage. In the two other patients (ACH19974 and ACH18897), the R286K mutation was present in all viral variants isolated at all time points, which suggests that this variant might be selected as a result of DR11-specific CTLs. However, this mutation is observed in 20 % of the viral sequences obtained from participants of the ACS (data not shown) regardless of HLA typing and therefore it cannot be excluded that this mutation was already present in the virus at the moment of transmission. In two out of seven patients, a mutation in the IK9 epitope emerged during the course of infection. In patient ACH19490, a mutation at position 26 (K26S/A) was positively selected during the course of infection. A mutation at the same position (K26R) was also observed in patient ACH18897 in all viral sequences obtained at 124 months after seroconversion and remained present in the viral population at 126 months after seroconversion. The emergence of mutations in DR11 and IK9 could also not be linked to an increase in the viral load.
Collectively, our data show maintenance of viral suppression despite emergence of mutations in HLA-B27 CTL-restricted IK9, DR11 or KK10 epitopes, which is in agreement with previous observations (Ammaranond et al., 2011; Kelleher et al., 2001; O'Connell et al., 2010a) . Similarly, control of virulence was retained despite emergence of CTL escape mutations in HLA-B57-positive elite controllers and recently infected individuals (Bailey et al., 2006b; Durand et al., 2010; Goonetilleke et al., 2009 ; O'Connell et al., 2010a).
Notably, the viral sequences obtained from all patients show very low genetic diversity in gag, which is most likely a result of the low level of viral replication in these patients, allowing fewer errors to be made by the enzyme reverse transcriptase throughout disease progression (Edo-Matas et al., 2011).
In conclusion, we analysed the sequence variation in HLA-B27-restricted CTL epitopes in longitudinal gag sequences from seven HLA-B27-positive patients during the course of infection and around the time of AIDS diagnosis. Sequence variations were mainly observed in the IK9, KK10 and DR11 CTL epitopes. However, the emergence of mutations could not be linked to an increase in viral load in the majority of the patients studied. The low genetic diversity and preservation of the Gag protein throughout the course of infection is suggestive of low-level viral replication in the HLA-B27-positive patients, which coincides with the low viral loads observed. Our findings indicate that control of viral replication can be preserved despite the emergence of mutations in the CTL-restricted epitopes in HLA-B27-positive patients.
METHODS
Patient selection. Seven participants of the ACS, who were followed longitudinally and from whom serum samples were available, were analysed in this study (Table 1 ). All participants had routine 3 monthly visits for blood donation and physical examination. All patients reached AIDS diagnosis [Centers for Disease Control 1993 definition (Centers for Disease Control, 1992) or CD4 + T-cell counts v200 cells ml 21 ] without the use of antiretroviral treatment. Selection of serum samples was done on the basis of a viral load w1000 copies ml 21 around the time of disease progression (between 2 years before and 6 months after AIDS diagnosis). The ACS have been conducted in accordance with the ethical principles set out in the Declaration of Helsinki and written informed consent was obtained prior to data collection. This study was approved by the Amsterdam Medical Center institutional medical ethics committee.
RNA isolation, reverse transcription-PCR and PCR amplification. Viral RNA was isolated from 150 ml serum with a QIAmp Viral Mini kit according to the manufacturer's protocol. Subsequently, viral RNA was transcribed into cDNA using M-MLV Reverse Transcriptase (Invitrogen) and the Gag-specific primer gag outer reversed (59-GCCTGTCTCTCAGTAC-39). DNA was amplified by a nested PCR with outer primers gag forward (59-CGACGCAGGACTCGGCTTGCTG-39) and gag outer reversed (59-GCCTGTCTCTCAGTAC-39) and inner PCR primer combinations: gag Bss HII fw (59-TGCTGAAGCGCCCGCACGGC-39) in combination with gag Apa I rev (59-TTCCTAGGGGCCCTGCAA-39). High-fidelity Taq polymerase (Roche) was used for amplification to limit possible amplification errors.
Molecular cloning and sequencing. Second-round PCR products were cloned into a pGEM-T Easy Vector System (Promega), transformed into competent DH5a Escherichia coli (Invitrogen) and plated on LB agar using blue/white screening. White colonies were picked at random. The vector primers T7 and SP6 were used to amplify the cloned gag regions. PCR products were purified with ExoSap-IT (USB) and sequenced with an ABI Prism BigDye Terminator sequencing kit (Perkin Elmer) on an ABI 3130xl DNA sequencer according to the manufacturer's protocol. Sequences were analysed using CodonCode Aligner software. The nucleotide sequences of the gag region were translated and analysed with the BioEdit program (version 7.0.5). Statistical analysis of the number of changes in the gag region was done using Student's t-test (GraphPad Prism version 5.01).
Genetic divergence and selection pressure. Genetic divergence between the viral sequences isolated from two successive time points was analysed using the Kimura two-parameter model of evolution (Kimura, 1980) in the MEGA6 software package. Genetic selection pressure on the viruses was analysed by determining the number of non-synonymous (dN) and synonymous (dS) mutations with the SNAP tool from the Los Alamos database website (http://www.hiv.lanl.gov) (Korber, 2000) . dN/dS ratios were calculated comparing viral variants isolated from two successive time points.
